Third Rock Ventures II, L.P. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Third Rock Ventures II, L.P..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is a 10% Owner in MyoKardia Inc ($MYOK) and a 10% Owner in Blueprint Medicines Corp ($BPMC) and a 10% Owner in Sage Therapeutics, Inc. ($SAGE) and a 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and a 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and a 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and a 10% Owner in Revolution Medicines, Inc. ($RVMD).

Address: 29 NEWBURY STREET, 3RD FLOOR BOSTON 02116 MA

Companies in which Third Rock Ventures II, L.P. is an Insider

Allena Pharmaceuticals, Inc.

Trading Symbol: ALNA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,575,964 shares
Latest Transaction: Nov 06 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Blueprint Medicines Corp

Trading Symbol: BPMC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 4,453,753 shares
Current Value: $159,622,508
Latest Transaction: Feb 09 2017
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Global Blood Therapeutics, Inc.

Trading Symbol: GBT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,475,191 shares
Current Value: $40,098,094
Latest Transaction: Jun 16 2017
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Jounce Therapeutics, Inc.

Trading Symbol: JNCE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 4,447,829 shares
Current Value: $76,947,442
Latest Transaction: Jun 14 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MyoKardia, Inc.

Trading Symbol: MYOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 885,104 shares
Current Value: $10,621,248
Latest Transaction: Mar 07 2018
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Revolution Medicines, Inc.

Trading Symbol: RVMD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 1,774,317 shares
Latest Transaction: May 27 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sage Therapeutics, Inc.

Trading Symbol: SAGE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,892,916 shares
Current Value: $137,992,093
Latest Transaction: Aug 19 2016
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Third Rock Ventures II, L.P.

Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 14 2021JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,500,00004,447,8295.9 M to 4.4 M (-25.22 %)
May 27 2021RVMDRevolution Medicin ...Third Rock Ventures II, L.P.10% OwnerSellS30.531,231,20437,588,658543,1131.8 M to 543.1 K (-69.39 %)
May 27 2021RVMDRevolution Medicin ...Third Rock Ventures II, L.P.10% OwnerSellS30.93135,0004,175,5501,774,3171.9 M to 1.8 M (-7.07 %)
Mar 15 2021JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,250,00006,500,3497.8 M to 6.5 M (-16.13 %)
Nov 19 2020JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellS7.2515,000108,7739,215,3499.2 M to 9.2 M (-0.16 %)
Nov 13 2020JNCEJounce Therapeutic ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00009,230,34910.2 M to 9.2 M (-9.77 %)
Mar 07 2018MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSellJ0.002,000,0000885,1042.9 M to 885.1 K (-69.32 %)

View all Third Rock Ventures II, L.P. insider transactions.